SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-039896
Filing Date
2013-05-10
Accepted
2013-05-10 08:02:45
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-7919_110q.htm 10-Q 791331
2 EX-31.1.1 a13-7919_1ex31d1d1.htm EX-31.1.1 12316
3 EX-31.2.1 a13-7919_1ex31d2d1.htm EX-31.2.1 12411
4 EX-32.1 a13-7919_1ex32d1.htm EX-32.1 6995
  Complete submission text file 0001104659-13-039896.txt   7357490

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT osir-20130331.xml EX-101.INS 1139783
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20130331.xsd EX-101.SCH 64533
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20130331_cal.xml EX-101.CAL 54854
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20130331_def.xml EX-101.DEF 251312
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20130331_lab.xml EX-101.LAB 1063920
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20130331_pre.xml EX-101.PRE 513867
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 13831122
SIC: 2836 Biological Products, (No Diagnostic Substances)